Analyst
MST Access
Chris Kallos
Life Sciences Analyst
Request Access
About
Chris Kallos, CFA, is a healthcare and biotech equities analyst who has been active since 1998 and has extensive experience in both Australian and US stocks. He has covered small, medium and large cap stocks for a range of research houses in Australia, the United Kingdom and the United States. Chris holds a Bachelor of Pharmacy (Sydney), an MBA from the AGSM (UNSW), and a Masters of Applied Finance (Macquarie). He is a CFA charterholder and graduate of the Australian Institute of Company Directors. Chris Kallos is an authorised representative of Bridge Investment Research Pty Ltd, which is an authorised representative of MST Financial.
Stock Coverage
Race Oncology
RAC.AX
Recce Pharmaceuticals Limited
RCE.AX
AVITA Medical Inc
AVH.AX
INOVIQ Ltd
IIQ.AX
CardieX Limited
CDX.AX
Cynata Therapeutics Limited
CYP.AX
Adherium Ltd
ADR.AX
Acrux Limited
ACR.AX
EZZ Life Science Holdings Ltd
EZZ.AX
Syntara Limited
SNT.AX
Request Access
Unlock comprehensive
analyst research and insights.
Already have an account? Log in